Arménie -
angličtina -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
emend powder lyophilized for solution for infusion
merck sharp & dohme b.v. - fosaprepitant (fosaprepitant dimeglumine) - powder lyophilized for solution for infusion - 150mg
Malta -
angličtina -
Medicines Authority
aprepitant rontis capsules hard 80mg
rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 80 mg - antiemetics and antinauseants
Malta -
angličtina -
Medicines Authority
aprepitant rontis capsules hard 125mg
rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 125 mg - antiemetics and antinauseants
Malta -
angličtina -
Medicines Authority
aprepitant rontis capsules hard 80mg & 125mg
rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 80 mg aprepitant 125 mg - antiemetics and antinauseants
Irsko -
angličtina -
HPRA (Health Products Regulatory Authority)
aprepitant accord 125 mg hard capsules
accord healthcare ireland ltd. - aprepitant - capsule, hard - 125 milligram(s) - aprepitant
Irsko -
angličtina -
HPRA (Health Products Regulatory Authority)
aprepitant accord 125 mg/80 mg hard capsules
accord healthcare ireland ltd. - aprepitant; aprepitant - capsule, hard - 80/125 milligram(s) - aprepitant
Irsko -
angličtina -
HPRA (Health Products Regulatory Authority)
aprepitant accord 80 mg hard capsules
accord healthcare ireland ltd. - aprepitant - capsule, hard - 80 milligram(s) - aprepitant
Izrael -
angličtina -
Ministry of Health
emend 125 mg capsules
merck sharp & dohme israel ltd - aprepitant - capsules - aprepitant 125 mg - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
Jordánsko -
angličtina -
JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
ivemend 150 mg
مستودع أدوية أداتكو - adatco drug store - fosaprepitant 150 mg - 150 mg
Izrael -
angličtina -
Ministry of Health
emend iv 150 mg
merck sharp & dohme israel ltd - fosaprepitant as fosaprepitant dimeglumine 150 mg - powder for solution for infusion - aprepitant - emend iv 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.